Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_assertion type Assertion NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_head.
- NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_assertion description "[Vasoactive intestinal peptide (VIP) exerts similar effects in prostate cancer models involving increased expression of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) which are related to NF-?B transactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_provenance.
- NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_assertion evidence source_evidence_literature NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_provenance.
- NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_assertion SIO_000772 25446255 NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_provenance.
- NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_assertion wasDerivedFrom befree-2016 NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_provenance.
- NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_assertion wasGeneratedBy ECO_0000203 NP1242093.RAH6_mX4dLVYXnVreYU5NaUg0pIzt8_P_DePB0154vOQ4130_provenance.